Hypertension Diagnostics, Inc.

HDIIOTCFinancial Services● Active

$0.00

+$0.00(+0.00%)

Market Cap$13681

P/E Ratio—

52W High$0.0002

52W Low$0.0001

Avg Volume50K

Open$0.00

Beta-53.23

Overview

Hypertension Diagnostics, Inc. (HDII) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

HDII · earnings · updated Jun 9, 2026

Latest Earnings

Q3 FY2019Report Date: Sep 30, 2019

EPS Actual

$0.01

Revenue

—

Fiscal Period

Q3 FY2019

FY ends December

Report Date

Sep 30, 2019

After Market Close

HDII reports quarterly as a OTC-listed Shell Companies company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q3 FY2019	Sep 30, 2019	—	$0.01	—	—	—	—
— Q2 FY2013	May 15, 2013	—	-$0.01	—	$0.00B	—	—
— Q1 FY2013	Feb 14, 2013	—	-$0.01	—	$0.00B	—	—
— Q3 FY2012	Sep 30, 2012	—	-$0.01	—	$0.00B	—	—
— Q2 FY2012	Jun 30, 2012	—	-$0.01	—	$0.00B	—	—
— Q1 FY2012	Mar 31, 2012	—	$0.00	—	$0.00B	—	—
— Q4 FY2011	Dec 31, 2011	—	-$0.00	—	$0.00B	—	—
— Q3 FY2011	Sep 30, 2011	—	-$0.02	—	$0.00B	—	—

Q3 FY2019

Sep 30, 2019

EPS Actual

$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2013

May 15, 2013

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q1 FY2013

Feb 14, 2013

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q3 FY2012

Sep 30, 2012

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q2 FY2012

Jun 30, 2012

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q1 FY2012

Mar 31, 2012

EPS Actual

$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q4 FY2011

Dec 31, 2011

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q3 FY2011

Sep 30, 2011

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

No analyst estimates available for HDII.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q3 FY2019	Sep 30, 2019	—	$0.02	$0.01	-33.30%
— Q2 FY2013	May 15, 2013	—	$0.04	$0.04	+0.00%
— Q1 FY2013	Feb 14, 2013	—	$0.01	$0.01	+0.00%
— Q3 FY2012	Sep 30, 2012	—	$0.04	$0.04	+0.00%
— Q2 FY2012	Jun 30, 2012	—	$0.02	$0.02	+0.00%
— Q1 FY2012	Mar 31, 2012	—	$0.06	$0.06	+0.00%
— Q4 FY2011	Dec 31, 2011	—	$0.09	$0.07	-17.65%
— Q3 FY2011	Sep 30, 2011	—	$0.10	$0.10	+0.00%

Q3 FY2019-33.30%

Report Date

Sep 30, 2019

EPS Beat/Miss

—

Price Before

$0.02

Price After

$0.01

Q2 FY2013+0.00%

Report Date

May 15, 2013

EPS Beat/Miss

—

Price Before

$0.04

Price After

$0.04

Q1 FY2013+0.00%

Report Date

Feb 14, 2013

EPS Beat/Miss

—

Price Before

$0.01

Price After

$0.01

Q3 FY2012+0.00%

Report Date

Sep 30, 2012

EPS Beat/Miss

—

Price Before

$0.04

Price After

$0.04

Q2 FY2012+0.00%

Report Date

Jun 30, 2012

EPS Beat/Miss

—

Price Before

$0.02

Price After

$0.02

Q1 FY2012+0.00%

Report Date

Mar 31, 2012

EPS Beat/Miss

—

Price Before

$0.06

Price After

$0.06

Q4 FY2011-17.65%

Report Date

Dec 31, 2011

EPS Beat/Miss

—

Price Before

$0.09

Price After

$0.07

Q3 FY2011+0.00%

Report Date

Sep 30, 2011

EPS Beat/Miss

—

Price Before

$0.10

Price After

$0.10

Beat Rate0 / 8 quarters

Largest Move-33.30% (Q3 FY2019)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Hypertension Diagnostics, Inc. (HDII) most recently reported earnings on September 30, 2019 for Q3 FY2019, posting EPS of $0.01 (in line with the analyst consensus of —). The next HDII earnings date is expected around September 1, 2026.

Each quarter, investors track HDII earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HDII revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

HDII's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

HDII earnings · 4 questions

Hypertension Diagnostics, Inc.'s next earnings report is expected around September 1, 2026. HDII typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HDII historically reports after market close (AMC).

HDII earnings datewhen is HDII earningsHDII next earnings datewhen does HDII report earningsHDII earnings calendar

▸ Source: FMP · Hypertension Diagnostics, Inc. SEC filings · US GAAP · Hypertension Diagnostics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026